These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7746176)

  • 41. Hormone replacement therapy shortens QT dispersion in healthy postmenopausal women.
    Yildirir A; Aybar F; Kabakci MG; Yarali H; Akgul E; Bukulmez O; Tokgozoglu SL; Gurgan T; Oto A
    Ann Noninvasive Electrocardiol; 2001 Jul; 6(3):193-7. PubMed ID: 11466136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of serum estrogen levels with uterine and carotid arteries flow in postmenopausal women on hormone replacement therapy.
    Predanic M; Ujevic B; Aleem F; Pennisi J
    Croat Med J; 1998 Jun; 39(2):181-4. PubMed ID: 9575274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy.
    Wu MH; Pan HA; Wang ST; Hsu CC; Chang FM; Huang KE
    Climacteric; 2001 Dec; 4(4):314-9. PubMed ID: 11770188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma homocysteine in women taking hormone replacement therapy: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
    Barnabei VM; Phillips TM; Hsia J
    J Womens Health Gend Based Med; 1999 Nov; 8(9):1167-72. PubMed ID: 10595329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overweight and effect of hormone replacement therapy on lipid profiles in postmenopausal women.
    Ko HS; Kim CJ; Ryu WS
    Korean J Intern Med; 2005 Mar; 20(1):33-9. PubMed ID: 15906951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HRT decreases DNA and lipid oxidation in postmenopausal women.
    Escalante Gómez C; Quesada Mora S
    Climacteric; 2013 Feb; 16(1):104-10. PubMed ID: 22530644
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IMS updates its recommendations on the use of HRT.
    Brown S
    Menopause Int; 2013 Sep; 19(3):105-6. PubMed ID: 24195130
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of estrogen-progestin treatment on opioid control of gonadotropin and prolactin secretion in postmenopausal women.
    Dawood MY; Khan-Dawood FS; Ramos J
    Am J Obstet Gynecol; 1986 Dec; 155(6):1246-51. PubMed ID: 3024488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial.
    Greenspan SL; Resnick NM; Parker RA
    JAMA; 2003 May; 289(19):2525-33. PubMed ID: 12759324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of hormone replacement therapy on bone mass in patients with ovarian failure due to bone marrow transplantation.
    Castelo-Branco C; Rovira M; Pons F; Durán M; Sierra J; Vives A; Balasch J; Fortuny A; Vanrell J
    Maturitas; 1996 Apr; 23(3):307-12. PubMed ID: 8794425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estrogen replacement therapy among postmenopausal women and its effects on signs and symptoms of temporomandibular disorders.
    Nekora-Azak A; Evlioglu G; Ceyhan A; Keskin H; Berkman S; Issever H
    Cranio; 2008 Jul; 26(3):211-5. PubMed ID: 18686498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of hormone replacement therapy and calcitonin on bone mass in postmenopausal women.
    Meschia M; Brincat M; Barbacini P; Maini MC; Marri R; Crosignani PG
    Eur J Obstet Gynecol Reprod Biol; 1992 Oct; 47(1):53-7. PubMed ID: 1330761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mammographic and ultrasonographic study of changes in the breast related to HRT.
    Ozdemir A; Konuş O; Nas T; Erbaş G; Coşar S; Işik S
    Int J Gynaecol Obstet; 1999 Oct; 67(1):23-32. PubMed ID: 10576236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sleep in menopause: differential effects of two forms of hormone replacement therapy.
    Montplaisir J; Lorrain J; Denesle R; Petit D
    Menopause; 2001; 8(1):10-6. PubMed ID: 11201509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estrogen replacement therapy and memory in older women.
    Robinson D; Friedman L; Marcus R; Tinklenberg J; Yesavage J
    J Am Geriatr Soc; 1994 Sep; 42(9):919-22. PubMed ID: 8064097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
    Kalyan S; Hitchcock CL; Sirrs S; Pudek M; Prior JC
    Pharmacotherapy; 2010 May; 30(5):442-52. PubMed ID: 20411996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential prevalence of quality-of-life categories (domains) in Asian women and changes after therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study.
    Limpaphayom KK; Darmasetiawan MS; Hussain RI; Burriss SW; Holinka CF; Ausmanas MK
    Climacteric; 2006 Jun; 9(3):204-14. PubMed ID: 16766434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of hormone replacement therapy on serum levels of tumor markers in healthy postmenopausal women.
    Cengiz B; Atabekoglu C; Cetinkaya E; Cengiz SD
    Maturitas; 2003 Dec; 46(4):301-6. PubMed ID: 14625127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human versus non-human sex steroid use in hormone replacement therapies part 1: Preclinical data.
    Atwood CS; Ekstein SF
    Mol Cell Endocrinol; 2019 Jan; 480():12-35. PubMed ID: 30308266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women.
    Bar J; Tepper R; Fuchs J; Pardo Y; Goldberger S; Ovadia J
    Obstet Gynecol; 1993 Feb; 81(2):261-4. PubMed ID: 8380912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.